Lexington, MA, United States of America

Chun-Hyung Kim

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Chun-Hyung Kim

Introduction

Chun-Hyung Kim is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on aminoquinoline derivatives. With a total of 3 patents, his research focuses on developing compounds that can be used to treat various medical conditions.

Latest Patents

Chun-Hyung Kim's latest patents include groundbreaking work on aminoquinoline and aminoacridine based hybrids. These patents describe pharmaceutical compositions and medicaments that incorporate these hybrids. The methods outlined in his patents aim to diagnose and treat infections, neurodegenerative diseases, inflammation, and disorders that can be managed with dopamine agonists, such as restless leg syndrome. His research is pivotal in advancing treatment options for these conditions.

Career Highlights

Throughout his career, Chun-Hyung Kim has worked with notable institutions, including the McLean Hospital Corporation and the University of Delhi. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.

Collaborations

Chun-Hyung Kim has collaborated with several professionals, including Kwang-Soo Kim and Diwan S Rawat. These partnerships have enhanced his research and expanded the impact of his innovations.

Conclusion

Chun-Hyung Kim's contributions to the field of pharmaceuticals through his patents on aminoquinoline derivatives demonstrate his commitment to advancing medical science. His work continues to influence the development of treatments for various diseases and disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…